Kee Song Bio-Technology Holdings Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 3,039.331 million compared to TWD 2,835.038 million a year ago. Operating loss was TWD 117.583 million compared to TWD 81.406 million a year ago. Net loss was TWD 124.691 million compared to TWD 149.192 million a year ago. Basic loss per share was TWD 3.39 compared to TWD 4.05 a year ago.